These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22958742

  • 1. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
    Huang Y, Zhang J, Cui ZM, Zhao J, Zheng Y.
    Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
    Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM.
    PLoS One; 2009 Aug 19; 4(8):e6695. PubMed ID: 19690611
    [Abstract] [Full Text] [Related]

  • 4. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
    Hu W, Liu Y, Zhou W, Si L, Ren L.
    PLoS One; 2014 Aug 19; 9(6):e99056. PubMed ID: 24897301
    [Abstract] [Full Text] [Related]

  • 5. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
    Hu W, Zhen X, Xiong B, Wang B, Zhang W, Zhou W.
    Cancer Sci; 2008 Jul 19; 99(7):1362-9. PubMed ID: 18452560
    [Abstract] [Full Text] [Related]

  • 6. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O.
    J Immunol; 2003 Feb 01; 170(3):1136-40. PubMed ID: 12538668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, Brand S.
    Inflamm Bowel Dis; 2010 Nov 01; 16(11):1871-81. PubMed ID: 20848509
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK, Lee W, Park HJ, Lee SD, Lee JZ, Chung MK.
    Mol Med Rep; 2011 Nov 01; 4(3):419-24. PubMed ID: 21468586
    [Abstract] [Full Text] [Related]

  • 11. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.
    Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, Berry JE, McGee S, Lee E, Sun H, Wang J, Jin T, Zhang H, Dai J, Krebsbach PH, Keller ET, Pienta KJ, Taichman RS.
    Nat Commun; 2013 Nov 01; 4():1795. PubMed ID: 23653207
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
    Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.
    Cancer Res; 2008 Jun 15; 68(12):4701-8. PubMed ID: 18559516
    [Abstract] [Full Text] [Related]

  • 15. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
    Deng L, Chen N, Li Y, Zheng H, Lei Q.
    Biochim Biophys Acta; 2010 Aug 15; 1806(1):42-9. PubMed ID: 20122997
    [Abstract] [Full Text] [Related]

  • 16. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
    Sawada S, Harada K, Isse K, Sato Y, Sasaki M, Kaizaki Y, Nakanuma Y.
    Pathol Int; 2007 Oct 15; 57(10):652-63. PubMed ID: 17803654
    [Abstract] [Full Text] [Related]

  • 17. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y, Wang J, Xu Y, Koch AE, Cai Z, Chen X, Galson DL, Taichman RS, Zhang J.
    Mol Cancer Res; 2008 Apr 15; 6(4):546-54. PubMed ID: 18344492
    [Abstract] [Full Text] [Related]

  • 18. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
    Xiao G, Wang X, Wang J, Zu L, Cheng G, Hao M, Sun X, Xue Y, Lu J, Wang J.
    Oncotarget; 2015 Jun 10; 6(16):14165-78. PubMed ID: 25909173
    [Abstract] [Full Text] [Related]

  • 19. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
    Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, Johannsen M, Jung K, Schaider H, Altevogt P, Ludwig A, Pfeilschifter J, Kristiansen G.
    Eur J Cancer; 2009 Feb 10; 45(3):478-89. PubMed ID: 19070478
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.